# DIAMEDICA THERAPEUTICS INC (DMAC)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DMAC/

- Reporting holders: 4
- Reported value: $105.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $39.9K | 4,824 | 0.0% | 21 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $38.9K | 4,703 | 0.0% | 4 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $23.2K | 2,810 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $3.5K | 426 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $105.5K |
| Q2 2026 | 92 | $94.1M |
| Q1 2026 | 100 | $80.0M |
| Q4 2025 | 92 | $96.5M |
| Q3 2025 | 77 | $83.2M |
| Q2 2025 | 59 | $34.5M |
| Q1 2025 | 59 | $28.5M |
| Q4 2024 | 46 | $36.9M |
| Q3 2024 | 40 | $23.5M |
| Q2 2024 | 33 | $15.0M |
| Q1 2024 | 34 | $13.3M |
| Q4 2023 | 38 | $11.3M |